Skip to content

Evolving Homoeopathic Approaches in ADHD: A Clinical Case-Based Study

Evolving the therapeutics in the treatment of attention deficit hyperactivity disorder through clinical cases An experimental uncontrolled study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/090544
Enrollment
80
Registered
2025-07-09
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F90- Attention-deficit hyperactivity disorders

Interventions

Intervention1: Individualized Homeopathic Remedy: 1) Individualized Homeopathic Remedy, Route: Oral, Dose: 4 globules stat. 2) Non-Medicated globules, Route: Oral, Dose: 4 globules/BD/Day/ Month for a

Sponsors

Dr Jairaj Mahaveer Patil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Subjects of both sexes between the age group of 5 to 15 years irrespective of their socioeconomic status shall be included under the subjects assent and parent s informed consent. 2) All three types (Predominately hyperactive-impulsive, predominately inattentive, combined hyperactive-impulsive and inattentive) of ADHD subjects clinically diagnosed cases as per Diagnostic Statistical Manual of Mental Disorder-V (DSM-V) shall be considered for the study. 3) Subjects with baseline score equal or greater than 37 on Vanderbilt ADHD diagnostic parent rating scale (VADPRS) shall be included.

Exclusion criteria

Exclusion criteria: 1) Subjects with Intellectual disability (Mental retardation). 2) Subjects with other mental disorders, OCD, Schizophrenia. 3) Subjects having history of any medical illness like hypothyroidism, genetic disorder and neurological disorders. 4) Subjects having congenital deformity. 5) Subjects who are on any other medications for known chronic illness like allergic conditions, systemic illness, failures of vital organs or systems as detected clinically.

Design outcomes

Primary

MeasureTime frame
Outcome will be assessed as the change in the pre and post intervention scores as assessed using the Vanderbilt ADHD Diagnostic Parent Rating Scale (VADPRS) over a period of 6 monthsTimepoint: Outcome will be assessed/estimated at baseline, and subsequently on a monthly basis for a duration of 6 months.

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDr Jairaj Mahaveer Patil

SJPEs Homoeopathic Medical College and Hospital

mrkulkarni242@gmail.com9850839483

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026